{"meta":{"query_hash":"11b50837ba6f","filters":{"venue":"Oncolytic Virotherapy"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/11b50837ba6f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Oncolytic+Virotherapy"},"results":[{"id":"W1967880037","doi":"10.2147/ov.s31626","title":"Oncolytic virotherapy for ovarian cancer","year":2012,"lang":"en","type":"article","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Cancer Society Research Institute; National Institutes of Health","keywords":"Oncolytic virus; Ovarian cancer; Virotherapy; Cancer; Carcinogenesis; Clinical trial; Medicine; Oncology; Biology; Cancer research; Computational biology; Bioinformatics; Internal medicine","score_opus":0.03151637678982602,"score_gpt":0.3604665557516404,"score_spread":0.32895017896181433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967880037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96872294,0.010271548,0.010732433,0.0020249463,0.0010005165,0.0036532087,0.00016087903,0.000106302796,0.003327225],"genre_scores_gemma":[0.96192735,0.003893855,0.002923046,0.007142598,0.0053878613,0.0031045894,0.00011998287,0.0003776288,0.015123064],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732226,0.00016920001,0.00040283622,0.0005945317,0.0003919066,0.001119246],"domain_scores_gemma":[0.9984172,0.00006529998,0.00014702359,0.00085794635,0.00012416019,0.0003883868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008377826,0.00042734703,0.00039966268,0.00012674248,0.0002572088,0.00006555046,0.000537035,0.0003378621,0.00089767994],"category_scores_gemma":[0.00004012041,0.00040132244,0.000299471,0.00024204577,0.00016957971,0.000020753518,0.00005068803,0.00019379344,0.00009130385],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049844244,0.0004961915,0.0022588575,0.000029202485,0.0003388955,0.0000012389233,0.00025162258,0.000063017585,0.8845474,0.00021683984,0.006547655,0.10026462],"study_design_scores_gemma":[0.005490429,0.004406569,0.0010555137,0.000027996708,0.000034318764,0.000011928866,0.00006302138,0.0002122685,0.445898,0.00019350954,0.54197836,0.00062808814],"about_ca_topic_score_codex":0.00007038255,"about_ca_topic_score_gemma":0.00024118496,"teacher_disagreement_score":0.53543067,"about_ca_system_score_codex":0.00020981202,"about_ca_system_score_gemma":0.0004376285,"threshold_uncertainty_score":0.99984384},"labels":[],"label_agreement":null},{"id":"W1977362391","doi":"10.2147/ov.s59640","title":"The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)","year":2015,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Vaccinia; Immunotherapy; Hepatocellular carcinoma; Cancer research; Cancer; Medicine; Immunology; Colorectal cancer; Immune system; Virotherapy; Biology; Internal medicine","score_opus":0.03707615220644535,"score_gpt":0.3786682573576426,"score_spread":0.34159210515119726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977362391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021443854,0.9953862,0.00009444964,0.00017341047,0.00064139365,0.00238871,0.000077549215,0.000017833401,0.0010060023],"genre_scores_gemma":[0.0017694939,0.99135697,0.00002408594,0.0001821182,0.0005620672,0.00054624816,0.000060026647,0.0001827146,0.0053162486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635255,0.00064858265,0.00081275834,0.0006559133,0.00078875705,0.0007414325],"domain_scores_gemma":[0.9971417,0.000088570734,0.00064196804,0.0018039526,0.00016454152,0.00015925607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007421272,0.0006782445,0.0011375479,0.00009016421,0.0004346128,0.00012181643,0.0015650893,0.0004278917,0.00007215247],"category_scores_gemma":[0.000033475302,0.00036673565,0.0011608219,0.00042847788,0.00049542147,0.000007663897,0.0002456039,0.0004866508,0.000050142535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018750507,0.0001880834,0.000009204841,0.00048848044,0.0016455667,0.0000058878563,0.000052261345,0.0000055451183,0.0010107277,0.00005257099,0.0009960097,0.99535817],"study_design_scores_gemma":[0.0014235119,0.00066778803,0.000015302365,0.0008555008,0.0005433936,0.00006802821,0.000044794204,0.000015562768,0.0003002045,0.0001733144,0.9955098,0.000382771],"about_ca_topic_score_codex":0.00017068969,"about_ca_topic_score_gemma":0.00016933352,"teacher_disagreement_score":0.9949754,"about_ca_system_score_codex":0.0003852884,"about_ca_system_score_gemma":0.002320965,"threshold_uncertainty_score":0.99987847},"labels":[],"label_agreement":null},{"id":"W1992223911","doi":"10.2147/ov.s45525","title":"The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications","year":2015,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ontario Institute for Cancer Research; Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Ex vivo; Virus; Herpes simplex virus; Immunology; Context (archaeology); Vaccinia; Cancer; Virology; Cancer research; Medicine; Biology; In vivo; Internal medicine","score_opus":0.1445093680993037,"score_gpt":0.501463198130461,"score_spread":0.3569538300311573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992223911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011027262,0.99580336,0.0000808119,0.00011181619,0.0003605938,0.0020414714,0.00021615376,0.0000127916755,0.00027029053],"genre_scores_gemma":[0.000019143075,0.9978592,0.00019802718,0.00022787652,0.0006583806,0.00032061618,0.000023021885,0.0001370551,0.0005567127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99652046,0.00065899576,0.0011536888,0.00077168597,0.00038123463,0.0005139416],"domain_scores_gemma":[0.99720967,0.00025684532,0.0007643433,0.0012174402,0.00027999136,0.00027168193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014926288,0.000501112,0.001296891,0.000093799725,0.00021263976,0.00006779975,0.0007922775,0.0005146797,0.00007320531],"category_scores_gemma":[0.00008084469,0.0003487763,0.0004377167,0.00035631863,0.00060255325,0.000009037318,0.00017046943,0.00039197574,0.000012283688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003840577,0.00015671081,0.000027979817,0.0005743036,0.0004741345,0.0000011316364,0.000013272562,0.000008224815,0.0055275843,0.00000890911,0.0010526121,0.9917711],"study_design_scores_gemma":[0.00076615927,0.0016448956,0.0000017161501,0.00068531133,0.00028748307,0.000009478545,0.000017856868,0.000021170088,0.002432839,0.000065692424,0.99369377,0.00037365747],"about_ca_topic_score_codex":0.0000407261,"about_ca_topic_score_gemma":0.00053595536,"teacher_disagreement_score":0.99264115,"about_ca_system_score_codex":0.00025156437,"about_ca_system_score_gemma":0.0027068926,"threshold_uncertainty_score":0.9998964},"labels":[],"label_agreement":null},{"id":"W1998536901","doi":"10.2147/ov.s36623","title":"Cell carriers for oncolytic viruses: current challenges and future directions","year":2013,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Virus; Limiting; Virology; Immune system; Virotherapy; Medicine; Biology; Cancer research; Immunology","score_opus":0.07115610492401497,"score_gpt":0.38587240996775035,"score_spread":0.3147163050437354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998536901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014803819,0.99355227,0.000046594418,0.00011977921,0.0007467348,0.0043993127,0.00019229852,0.0000437308,0.00075122534],"genre_scores_gemma":[0.0000037314624,0.9908865,0.00023793917,0.00014740594,0.0032218304,0.003712184,0.00015825291,0.0002711507,0.0013609786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969817,0.00032035884,0.00058794307,0.0011162307,0.0003030768,0.0006906923],"domain_scores_gemma":[0.9980722,0.000110195164,0.0003187992,0.0009857265,0.00016210185,0.00035095337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000434487,0.0007959838,0.0013422566,0.00022793151,0.00024088849,0.00009340162,0.00054727786,0.0007344144,0.0001026522],"category_scores_gemma":[0.00002991059,0.00067136483,0.0005800452,0.00021075706,0.00019075243,0.000009500022,0.00009763428,0.0004563965,0.000056506964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018806578,0.00017245367,2.696438e-7,0.0037635956,0.00030487677,0.0000011937103,0.00012962702,2.8983735e-7,0.0005470658,0.000021657934,0.0029965497,0.99187434],"study_design_scores_gemma":[0.0011848167,0.0033149524,5.3576747e-7,0.00068996963,0.00025216443,0.000016610089,0.00009278554,0.0000059903973,0.0004696948,0.000041222145,0.9932182,0.00071305543],"about_ca_topic_score_codex":0.000008326462,"about_ca_topic_score_gemma":0.000081062026,"teacher_disagreement_score":0.9911613,"about_ca_system_score_codex":0.00020543604,"about_ca_system_score_gemma":0.0010345955,"threshold_uncertainty_score":0.99957377},"labels":[],"label_agreement":null},{"id":"W2063924821","doi":"10.2147/ov.s51321","title":"Reovirus in cancer therapy: an evidence-based review","year":2014,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Cancer; Cancer therapy; Medicine; Internal medicine","score_opus":0.30804080071913004,"score_gpt":0.528756644501325,"score_spread":0.22071584378219494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063924821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032263164,0.9923628,0.000050400555,0.0023407005,0.00017590208,0.0046167416,0.000026339321,0.00007207791,0.00032276928],"genre_scores_gemma":[0.000007673672,0.97668743,0.0003077923,0.018367033,0.00072631735,0.0027305903,0.00009041691,0.00016060786,0.00092211965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99417776,0.0020366814,0.0014157775,0.0009341404,0.000519533,0.00091612927],"domain_scores_gemma":[0.9974633,0.00025874586,0.00046666668,0.0012114163,0.00009475139,0.0005051277],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024071198,0.000691703,0.005082217,0.00041539987,0.000054690783,0.000025676474,0.0005488718,0.00046156129,0.0021655827],"category_scores_gemma":[0.0005222437,0.0004857275,0.00084282545,0.0006003011,0.00019721898,0.00014582374,0.00003123387,0.0010998945,0.00021535183],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002577343,0.00026067713,0.00016149621,0.035789486,0.00010613347,0.00010809613,0.0000057475527,5.520529e-7,0.000011327866,0.000008907518,0.0044719707,0.9588179],"study_design_scores_gemma":[0.0012800277,0.0022115887,0.000056904108,0.2507827,0.00014266564,0.000054786673,8.563505e-7,0.000027604814,7.914254e-7,0.000007930866,0.74517846,0.0002556507],"about_ca_topic_score_codex":0.0005806603,"about_ca_topic_score_gemma":0.00020060127,"teacher_disagreement_score":0.9585622,"about_ca_system_score_codex":0.0008584319,"about_ca_system_score_gemma":0.0017867136,"threshold_uncertainty_score":0.99975944},"labels":[],"label_agreement":null},{"id":"W2168122442","doi":"10.2147/ov.s66079","title":"Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy","year":2015,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Virotherapy; Immunotherapy; Virus; Immunogenicity; Virology; Vesicular Stomatitis; Cancer immunotherapy; Medicine; Immunology; Immune system","score_opus":0.0450872497709337,"score_gpt":0.3856185311832006,"score_spread":0.3405312814122669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168122442","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017830128,0.9783263,0.00019899747,0.000063947635,0.00029308972,0.0029975013,0.000050343067,0.000034929108,0.00020472927],"genre_scores_gemma":[0.0031476999,0.993665,0.000085537824,0.00021407638,0.0004121761,0.0015818786,0.00005852447,0.00033346633,0.0005016781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954121,0.0012718635,0.0009377623,0.0009303812,0.00081466,0.00063319935],"domain_scores_gemma":[0.9970634,0.00014435805,0.0006836768,0.0017408115,0.00018987899,0.00017784786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001164817,0.00084253657,0.002050994,0.00034452576,0.00012084567,0.000061476865,0.0014060772,0.0007714431,0.00012772223],"category_scores_gemma":[0.000057561578,0.0006023006,0.0006359406,0.00082460034,0.00036444614,0.000013487637,0.0001666097,0.0006815266,0.000034115543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008447685,0.00042618054,0.0000016760436,0.0011778144,0.0006483972,0.000020524287,0.0004584851,0.000036840775,0.057861753,0.00003092511,0.000338706,0.9381539],"study_design_scores_gemma":[0.0018592237,0.0038042883,0.0000059135627,0.0019345315,0.0001603578,0.000013482286,0.000031694624,0.000092352675,0.019755084,0.0003069669,0.971298,0.00073810597],"about_ca_topic_score_codex":0.0011467629,"about_ca_topic_score_gemma":0.004691358,"teacher_disagreement_score":0.9709593,"about_ca_system_score_codex":0.000800069,"about_ca_system_score_gemma":0.0031545477,"threshold_uncertainty_score":0.99964285},"labels":[],"label_agreement":null},{"id":"W2227073990","doi":"10.2147/ov.s66083","title":"Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances","year":2016,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Rosetrees Trust; National Institute for Health and Care Research","keywords":"Oncolytic virus; Virotherapy; Immunotherapy; Immunogenic cell death; Medicine; Cancer; Cytotoxic T cell; Cancer research; Immune system; Clinical trial; Chemotherapy; Immunology; Biology; Internal medicine; In vitro","score_opus":0.026545109675986202,"score_gpt":0.36646457713543984,"score_spread":0.3399194674594536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227073990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032333357,0.98995787,0.0021471737,0.00052992726,0.00058438664,0.005065586,0.00016581938,0.00025951254,0.00096638],"genre_scores_gemma":[0.000029892284,0.98569435,0.0004932602,0.0021082533,0.0018957029,0.0037325704,0.00017794788,0.0015428402,0.0043252097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919825,0.00092772965,0.001560734,0.0023969917,0.0012679705,0.0018640286],"domain_scores_gemma":[0.994979,0.00021001975,0.0012495429,0.0027110043,0.00033521056,0.0005152084],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010525326,0.002176933,0.0033755687,0.00051340915,0.00039707305,0.00021682245,0.0020751837,0.0012643297,0.0020252925],"category_scores_gemma":[0.000023438792,0.0015216821,0.0010659896,0.0009902373,0.0007494371,0.000048106063,0.00012775103,0.0009554701,0.0002034988],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005260215,0.0005003912,0.00001551526,0.00095264125,0.0022495033,0.00002663301,0.0000950477,0.000010923105,0.011381549,0.000012062756,0.0009738378,0.9785217],"study_design_scores_gemma":[0.0069475845,0.009750471,0.0000025761258,0.005567181,0.00017341286,0.00010274734,0.00002048848,0.000008593253,0.0051210495,0.00008567675,0.9701113,0.0021088813],"about_ca_topic_score_codex":0.00003587898,"about_ca_topic_score_gemma":0.0003018158,"teacher_disagreement_score":0.9764128,"about_ca_system_score_codex":0.0009933211,"about_ca_system_score_gemma":0.0028517775,"threshold_uncertainty_score":0.9990971},"labels":[],"label_agreement":null},{"id":"W2320627933","doi":"10.2147/ov.s66217","title":"High-throughput screening to enhance oncolytic virus immunotherapy","year":2016,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Government of Canada; Terry Fox Research Institute; Ontario Institute for Cancer Research","keywords":"Oncolytic virus; Vaccinia; Herpes simplex virus; Virus; Computational biology; Disease; Biology; CRISPR; Virology; Medicine; Gene; Genetics","score_opus":0.03293868116363912,"score_gpt":0.3924652041768385,"score_spread":0.3595265230131994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320627933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005527184,0.98447484,0.009152993,0.00025910817,0.0006066641,0.003908246,0.0003043551,0.000114251125,0.00062683143],"genre_scores_gemma":[0.000045437013,0.9783827,0.002566437,0.0017660344,0.002532733,0.001658097,0.00020069606,0.0006722846,0.012175588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933325,0.00078176433,0.0013664038,0.0020871295,0.00091478974,0.001517417],"domain_scores_gemma":[0.99563897,0.00018880733,0.00060281565,0.0028463795,0.00018831332,0.0005347102],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0011679224,0.0014629143,0.0025833906,0.00046130424,0.00032957454,0.00018632515,0.0020641854,0.0011249967,0.0012325348],"category_scores_gemma":[0.000093642404,0.0011653452,0.001168242,0.00074277155,0.00027541872,0.000017955783,0.00031243952,0.0006641879,0.0017664715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014880783,0.00019927153,5.577209e-7,0.0005248646,0.0008781817,0.000024337254,0.000044552173,0.000008057955,0.0443592,0.000019741108,0.004306859,0.9481463],"study_design_scores_gemma":[0.001287845,0.0061811684,9.82806e-7,0.0040824423,0.00009289415,0.00004024003,0.0000069137163,0.000001689434,0.024247145,0.00005040251,0.9625878,0.0014205148],"about_ca_topic_score_codex":0.000088747904,"about_ca_topic_score_gemma":0.00020306709,"teacher_disagreement_score":0.9582809,"about_ca_system_score_codex":0.0005356895,"about_ca_system_score_gemma":0.0014489752,"threshold_uncertainty_score":0.99981207},"labels":[],"label_agreement":null},{"id":"W2794593274","doi":"10.2147/ov.s137159","title":"The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses","year":2018,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; In vivo; Clinical trial; Cancer; Medical physics; Biology; Biotechnology; Pathology; Internal medicine","score_opus":0.08023557482088156,"score_gpt":0.4780869901824264,"score_spread":0.39785141536154484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794593274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036203638,0.9601664,0.00050245464,0.000036737525,0.00020848574,0.0024775376,0.00030416576,0.000007716717,0.00009288825],"genre_scores_gemma":[0.0023397943,0.9963755,0.00013188802,0.000077749915,0.0005028218,0.0002708246,0.000067765206,0.00007614138,0.0001574866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960692,0.0006442211,0.001953384,0.0006736539,0.00025661796,0.00040294277],"domain_scores_gemma":[0.9971381,0.0007898653,0.000923558,0.00086902967,0.00017640444,0.00010306154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032962454,0.00037823862,0.0014134992,0.000060952374,0.000087519686,0.000045261597,0.0006065082,0.0004583927,0.00001713662],"category_scores_gemma":[0.00036282706,0.00026983046,0.0006453087,0.00019529063,0.0013454746,0.000009571997,0.00010834785,0.0003076154,0.0000014373068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005127079,0.0006692411,0.005868435,0.0031533553,0.0008663306,0.000003877127,0.000039288356,0.0000019505055,0.0010242952,0.00021349941,0.0032166068,0.979816],"study_design_scores_gemma":[0.0024670556,0.0068888515,0.00025936813,0.001817559,0.00020892326,0.000009509679,0.000059023474,0.00009802898,0.00093204575,0.00047677322,0.986382,0.0004008701],"about_ca_topic_score_codex":0.000019135983,"about_ca_topic_score_gemma":0.00065294054,"teacher_disagreement_score":0.9831654,"about_ca_system_score_codex":0.000058741578,"about_ca_system_score_gemma":0.0016643921,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W2901585058","doi":"10.2147/ov.s154494","title":"Development and applications of oncolytic Maraba virus vaccines","year":2018,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; Wilfrid Laurier University; University of Ottawa; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; University of Guelph; McMaster University","funders":"","keywords":"Oncolytic virus; Virus; Priming (agriculture); Immune system; Cancer; Vaccination; Virology; Antigen; Cancer vaccine; Viral vector; Medicine; Acquired immune system; Immunotherapy; Immunology; Biology; Cancer research; Internal medicine","score_opus":0.04029798762587887,"score_gpt":0.3695247003395902,"score_spread":0.3292267127137113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901585058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012006444,0.9951074,0.00043872214,0.000012797913,0.00006584092,0.0022639418,0.00005926911,0.000020110268,0.0008312854],"genre_scores_gemma":[0.000025149147,0.9937108,0.0014234836,0.00009794713,0.00070292875,0.0012767175,0.00016870457,0.00014456476,0.0024496967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975769,0.00016971058,0.000779257,0.0007567583,0.00031185572,0.00040555524],"domain_scores_gemma":[0.9983123,0.00005481445,0.0004026281,0.00093145116,0.00012401541,0.00017477538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005255351,0.00052291114,0.0011167931,0.00022314872,0.00013505199,0.00003642758,0.00059294933,0.0004844733,0.00014366537],"category_scores_gemma":[0.00002006887,0.0004489973,0.00027051725,0.00032964433,0.00020488836,0.0000040609584,0.00015595791,0.00020432046,0.000090063404],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021738786,0.00017177002,0.0000027403757,0.0019513892,0.00042290596,0.0000017133955,0.000042756034,2.4253507e-7,0.0026539962,0.000016103035,0.00069072796,0.9938283],"study_design_scores_gemma":[0.0006261889,0.0014086392,0.0000023505393,0.0008219974,0.00011396325,0.000025562093,0.000012740324,0.0000019764275,0.009295812,0.000021719909,0.9872261,0.00044293204],"about_ca_topic_score_codex":0.000009659354,"about_ca_topic_score_gemma":0.00017212349,"teacher_disagreement_score":0.9933853,"about_ca_system_score_codex":0.000116241055,"about_ca_system_score_gemma":0.0012425196,"threshold_uncertainty_score":0.99979615},"labels":[],"label_agreement":null}]}